Treatment of pityriasis amiantacea with infliximab.
Pham
Ryan K
RK
University of North Texas Health Science Center, Fort Worth, USA.
Chan
C Stanley
CS
Hsu
Sylvia
S
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D000069285:Infliximab; D008875:Middle Aged; D010915:Pityriasis / Q000188:drug therapy*; D012074:Remission Induction
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000069285:Infliximab